Key terms
About PXMD
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PXMD news
No recent news articles are available for PXMD
No recent press releases are available for PXMD
PXMD Financials
Key terms
Ad Feedback
PXMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PXMD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range